13 research outputs found
In situ micro gas tungsten constricted arc welding of ultra-thin walled 2.275 mm outer diameter grade 2 commercially pure titanium tubing
Ultra-thin walled cooling tubes for heat exchangers and condenser units have applications in multiple high-value manufacturing industries. Grade 2 commercially pure titanium (CP-2 Ti) requires far less mass to achieve the same mass flow handling abilities as stainless steel tubing yet it is more challenging to join, particularly at wall thicknesses less than 500 μm (termed ultra-thin walled tube). This paper presents a single-pass joinery method that produces reliable welds on 2.275 mm outer diameter (OD), 160 ± 10 μm wall thickness tubing with a service life of 20 of more years. This is achieved through an automated orbital gas tungsten constricted arc welding (GTCAW) process incorporating enveloping low-mass sleeves used in tandem with a buttressing internal gas pressure to support the molten metal and maintain consistent internal diameter inside the tube. The industrial applicability is demonstrated through the production of a 1:1 scale mock-up of a fixed geometry CO2 cooling circuit for a next-generation particle detector. The tensile strengths of the joints, 403.8 ± 4.2 MPa, exceed the tensile strength of the parent CP-2 Ti
Mesoscopic conductance and its fluctuations at non-zero Hall angle
We consider the bilocal conductivity tensor, the two-probe conductance and
its fluctuations for a disordered phase-coherent two-dimensional system of
non-interacting electrons in the presence of a magnetic field, including
correctly the edge effects. Analytical results are obtained by perturbation
theory in the limit . For mesoscopic systems the conduction
process is dominated by diffusion but we show that, due to the lack of
time-reversal symmetry, the boundary condition for diffusion is altered at the
reflecting edges. Instead of the usual condition, that the derivative along the
direction normal to the wall of the diffusing variable vanishes, the derivative
at the Hall angle to the normal vanishes. We demonstrate the origin of this
boundary condition from different starting points, using (i) a simplified
Chalker-Coddington network model, (ii) the standard diagrammatic perturbation
expansion, and (iii) the nonlinear sigma-model with the topological term, thus
establishing connections between the different approaches. Further boundary
effects are found in quantum interference phenomena. We evaluate the mean
bilocal conductivity tensor , and the mean and variance
of the conductance, to leading order in and to order
, and find that the variance of the conductance
increases with the Hall ratio. Thus the conductance fluctuations are no longer
simply described by the unitary universality class of the case,
but instead there is a one-parameter family of probability distributions. In
the quasi-one-dimensional limit, the usual universal result for the conductance
fluctuations of the unitary ensemble is recovered, in contrast to results of
previous authors. Also, a long discussion of current conservation.Comment: Latex, uses RevTex, 58 pages, 5 figures available on request at
[email protected]. Submitted to Phys. Rev.
Sitagliptin reduces cardiac apoptosis, hypertrophy and fibrosis primarily by insulin-dependent mechanisms in experimental type-II diabetes. Potential roles of GLP-1 isoforms
Background:Myocardial fibrosis is a key process in diabetic cardiomyopathy. However, their underlying mechanisms have not been elucidated, leading to a lack of therapy. The glucagon-like peptide-1 (GLP-1) enhancer, sitagliptin, reduces hyperglycemia but may also trigger direct effects on the heart.Methods:Goto-Kakizaki (GK) rats developed type-II diabetes and received sitagliptin, an anti-hyperglycemic drug (metformin) or vehicle (n=10, each). After cardiac structure and function assessment, plasma and left ventricles were isolated for biochemical studies. Cultured cardiomyocytes and fibroblasts were used for in vitro assays.Results:Untreated GK rats exhibited hyperglycemia, hyperlipidemia, plasma GLP-1 decrease, and cardiac cell-death, hypertrophy, fibrosis and prolonged deceleration time. Moreover, cardiac pro-apoptotic/necrotic, hypertrophic and fibrotic factors were up-regulated. Importantly, both sitagliptin and metformin lessened all these parameters. In cultured cardiomyocytes and cardiac fibroblasts, high-concentration of palmitate or glucose induced cell-death, hypertrophy and fibrosis. Interestingly, GLP-1 and its insulinotropic-inactive metabolite, GLP-1(9-36), alleviated these responses. In addition, despite a specific GLP-1 receptor was only detected in cardiomyocytes, GLP-1 isoforms attenuated the pro-fibrotic expression in cardiomyocytes and fibroblasts. In addition, GLP-1 receptor signalling may be linked to PPARδ activation, and metformin may also exhibit anti-apoptotic/necrotic and anti-fibrotic direct effects in cardiac cells.Conclusions:Sitagliptin, via GLP-1 stabilization, promoted cardioprotection in type-II diabetic hearts primarily by limiting hyperglycemia e hyperlipidemia. However, GLP-1 and GLP-1(9-36) promoted survival and anti-hypertrophic/fibrotic effects on cultured cardiac cells, suggesting cell-autonomous cardioprotective actionsThis work was supported by national funding from Ministerio de Educación y Ciencia (SAF2009-08367), Comunidad de Madrid (CCG10-UAM/
BIO-5289), and a unrestricted grant from by Merck/MS
Rhamnolipids: diversity of structures, microbial origins and roles
Rhamnolipids are glycolipidic biosurfactants produced by various bacterial species. They were initially found as exoproducts of the opportunistic pathogen Pseudomonas aeruginosa and described as a mixture of four congeners: α-L-rhamnopyranosyl-α-L-rhamnopyranosyl-β-hydroxydecanoyl-β-hydroxydecanoate (Rha-Rha-C10-C10), α-L-rhamnopyranosyl-α-L-rhamnopyranosyl-β-hydroxydecanoate (Rha-Rha-C10), as well as their mono-rhamnolipid congeners Rha-C10-C10 and Rha-C10. The development of more sensitive analytical techniques has lead to the further discovery of a wide diversity of rhamnolipid congeners and homologues (about 60) that are produced at different concentrations by various Pseudomonas species and by bacteria belonging to other families, classes, or even phyla. For example, various Burkholderia species have been shown to produce rhamnolipids that have longer alkyl chains than those produced by P. aeruginosa. In P. aeruginosa, three genes, carried on two distinct operons, code for the enzymes responsible for the final steps of rhamnolipid synthesis: one operon carries the rhlAB genes and the other rhlC. Genes highly similar to rhlA, rhlB, and rhlC have also been found in various Burkholderia species but grouped within one putative operon, and they have been shown to be required for rhamnolipid production as well. The exact physiological function of these secondary metabolites is still unclear. Most identified activities are derived from the surface activity, wetting ability, detergency, and other amphipathic-related properties of these molecules. Indeed, rhamnolipids promote the uptake and biodegradation of poorly soluble substrates, act as immune modulators and virulence factors, have antimicrobial activities, and are involved in surface motility and in bacterial biofilm development